MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,919 | -29.7% | 18,500 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $7,000 | +40.0% | 18,500 | +12.1% | 0.00% | +50.0% |
Q2 2022 | $5,000 | -28.6% | 16,500 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,000 | -56.2% | 16,500 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $16,000 | -68.0% | 16,500 | -44.1% | 0.00% | -73.3% |
Q3 2021 | $50,000 | -39.0% | 29,500 | 0.0% | 0.02% | -34.8% |
Q2 2021 | $82,000 | +9.3% | 29,500 | -11.9% | 0.02% | 0.0% |
Q1 2021 | $75,000 | +53.1% | 33,500 | 0.0% | 0.02% | +53.3% |
Q4 2020 | $49,000 | -36.4% | 33,500 | -10.7% | 0.02% | -51.6% |
Q2 2020 | $77,000 | +8.5% | 37,500 | 0.0% | 0.03% | -32.6% |
Q1 2020 | $71,000 | -34.3% | 37,500 | -0.4% | 0.05% | +4.5% |
Q4 2019 | $108,000 | -54.0% | 37,650 | -18.2% | 0.04% | -63.3% |
Q3 2019 | $235,000 | -35.4% | 46,019 | 0.0% | 0.12% | -40.9% |
Q2 2019 | $364,000 | +20.1% | 46,019 | +0.2% | 0.20% | -1.5% |
Q1 2019 | $303,000 | +100.7% | 45,919 | +68.4% | 0.21% | +87.3% |
Q4 2018 | $151,000 | – | 27,269 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |